Abstract
Background Although the rapidly rising transmission trend of COVID-19 in Wuhan has been controlled in late February 2020, the outbreak still caused a global pandemic afterward. Understanding Wuhan’s COVID-19 transmission dynamics and the effects of prevention approaches is of significant importance for containing virus global transmission. However, most of the recent studies focused on the early outbreaks without considering improvements in diagnostic capability and effects of prevention measures together, thus the estimated results may only reflect the facts in a given period of time.
Methods We constructed a stochastic susceptible-exposed-infected-quarantined-recovered (SEIQR) model, embedding with latent periods under different prevention measures and proportions of documented infections to characterize the Wuhan COVID-19 transmission cross different stages of the outbreak. The epidemiological parameters were estimated using a particle filtering approach.
Results Our model successfully reproduced the dynamics of the Wuhan local epidemic with two peaks on February 4 and February 12 separately. Prevention measures determined the time of reaching the first peak and caused an 87% drop in the Rt from 3.09 (95% CI, 2.10 to 3.63) to 0.41 (95% CI, 0.18 to 0.66). An improved diagnostic capability created the second peak and increased the number of documented infections. The proportion of documented infections changed from 23% (95% CI, 20% to 26%) to 37% (95% CI, 33% to 41%) when the detection kits were released after January 26, and later up to 73% (95% CI, 64% to 80%) after the diagnostic criteria were improved.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We thank for funding supports from the City University of Hong Kong (#7200573 and #9610416).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The daily numbers of newly confirmed cases from January 11 to March 10 were collected from the bulletins of the Wuhan Municipal Health Commission and Health Commission of Hubei Province.